Back to the program

Topic-Contributed Paper Session

Integrated Evidence Generation to Enable Dose Optimization in Oncology

Mon, Aug 7, 8:30 AM

Hong TianOrganizerYanping WangChair

Biopharmaceutical Section

3 Presentations

Design Strategy and Consideration for Oncology Dose-Optimization: An Industry Perspective

8:35 AM - 8:55 AM

Incorporating Patient Reported Outcomes in Dose Finding Clinical Trials

8:55 AM - 9:15 AM

Oncology Dose Selection Conundrum: can we pick the winner in a randomized dose ranging study?

9:15 AM - 9:35 AM

Chihche Lin (BeiGene)

Discussants

Joyce Cheng (FDA)

Yuan-Li Shen (FDA)

↑